A randomized,multicenter phase Ⅲ study of lobaplatin/etoposide versus cisplatin/etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer and circulating tumor cells(CTCs)as an exploratory biomarker .Cabazitaxel(Cbz)Vs Topote ......